Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Quadrivalent Influenza Vaccine in People Aged 3 Years and Above
NCT06800950Phase 3Not yet recruiting
- Sponsor
- Institute of Medical Biology
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza virus vaccine, quadrivalent, split virion in influenza, sponsored by Institute of Medical Biology. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
influenza virus vaccine, quadrivalent, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06800950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06800950.